ShockWave Medical, Inc.
SWAV
Rang in Aktien
#1704
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Aktienkurs
$334.75
Zuletzt synchronisiert: 2024-05-30
Marktkapitalisierung
$12.46B
Veränderung (1 Tag)
-0.02%
Veränderung (1 Jahr)
0.00%
Land
US
Handel ShockWave Medical, Inc. (SWAV)
Kategorie
Healthcare
Kursverlauf für ShockWave Medical, Inc. (SWAV)
Höchster Schlusskurs: $331.50 am 2024-05-01
Niedrigster Schlusskurs: $33.22 am 2019-03-01
Niedrigster Schlusskurs: $33.22 am 2019-03-01
Kursverlauf der Aktie von ShockWave Medical, Inc. von 2019 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2024 | 79.76% |
| 2023 | -16.80% |
| 2022 | 24.77% |
| 2021 | 83.14% |
| 2020 | 126.77% |
| 2019 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $100.56 | -21.41% |
US
|
|
| $93.07 | -2.95% |
IE
|
|
| $297.13 | -23.49% |
US
|
|
| $44.47 | -57.18% |
US
|
|
| $46.89 | -18.17% |
DE
|
